Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P‐NMR follow‐up study
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
A patient with mitochondrial myopathy due to complex III deficiency who was treated with vitamin K 3 (menadiol sodium diphosphate, 40 mg daily) and vitamin C showed clinical improvement. A 1‐year study with phosphorus 31 nuclear magnetic resonance (31 P‐NMR) monitoring has shown that (1) clinical and metabolic improvement was maintained by this therapy; (2) increasing the dose of vitamin K 3 to 80 mg daily improved the bioenergetic state of the patient's muscles at rest; (3) postexercise recovery was less responsive to the increased dose; and (4) a higher dose of vitamin K 3 (80 mg/day) did not produce side effects. The differential therapeutic effects of vitamin K 3 at rest and during exercise recovery are probably due to the differential kinetics of each metabolic state. Monitoring muscle bioenergetics with 31 P‐NMR is valuable in documenting therapeutic improvements in mitochondrial myopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnold, D. L., Matthews, P. M., & Radda, G. K. (1984) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910010303 · Cited by 442
EXAMINATION OF A MYOPATHY BY PHOSPHORUS NUCLEAR MAGNETIC RESONANCE
Gadian, D., Ross, B., Bore, P., Radda, G., Hockaday, J., Taylor, D., & Styles, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90186-0 · Cited by 86
Cited by
Mitochondrial Energetics and Therapeutics
Wallace, D. C., Fan, W., & Procaccio, V. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092314 · Cited by 730
Vitamin C: Update on physiology and pharmacology
Mandl, J., Szarka, A., & Bánhegyi, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00282.x · Cited by 451
“However, after an initial improvement documented by 31P nuclear magnetic resonance spectroscopy of muscle (Argov et al., 1986), this state was not sustained [menadione had to be discontinued because of its withdrawal by the Food and Drug Administration (Keightley et al., 2000)].”
BackgroundOxidative Phosphorylation Diseases: Disorders of Two Genomes
Shoffner, J. M., & Wallace, D. C. (1990) · Advances in Human Genetics · doi:10.1007/978-1-4757-9065-8_5 · Cited by 336
Ralph, S. J., Rodríguez-Enríquez, S., Neuzil, J., Saavedra, E., & Moreno-Sánchez, R. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.02.008 · Cited by 331
Hamaoka, T., McCully, K. K., Quaresima, V., Yamamoto, K., & Chance, B. (2007) · Journal of Biomedical Optics · doi:10.1117/1.2805437 · Cited by 329
Self-citation
Metadata
- Authors
- Argov, Z., Bank, W. J., Maris, J., Eleff, S., Kennaway, N. G., Olson, R. E., & Chance, B.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1986-06
- Volume
- 19
- Issue
- 6
- Pages
- 598-602
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2113808214
- Cited by
- 117
- References
- 2
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P‐NMR follow‐up study. https://app.cochat.ai/papers/10.1002/ana.410190615
- The paper
- Argov, Z., Bank, W. J., Maris, J., Eleff, S., Kennaway, N. G., Olson, R. E., & Chance, B. (1986). Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P‐NMR follow‐up study. Annals of Neurology. https://doi.org/10.1002/ana.410190615
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.